{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:52:08Z","timestamp":1791312728072,"version":"4.3.1"},"reference-count":335,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T00:00:00Z","timestamp":1560297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.biopha.2019.109128","type":"journal-article","created":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T23:36:54Z","timestamp":1561160214000},"page":"109128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"special_numbering":"C","title":["Traditional Chinese medicine combined with hepatic targeted drug delivery systems: A new strategy for the treatment of liver diseases"],"prefix":"10.1016","volume":"117","author":[{"given":"Zhe","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dereje","family":"Kebebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhidong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2019.109128_bib0005","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1038\/emm.2015.122","article-title":"Regulation of glucose metabolism from a liver-centric perspective","volume":"48","author":"Han","year":"2016","journal-title":"Exp. Mol. Med."},{"issue":"12","key":"10.1016\/j.biopha.2019.109128_bib0010","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.1093\/nar\/gkw462","article-title":"Dysregulated signaling hubs of liver lipid metabolism reveal hepatocellular carcinoma pathogenesis","volume":"44","author":"Lee","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0015","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/s41467-018-03898-2","article-title":"A proteomics landscape of circadian clock in mouse liver","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0020","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/07388551.2014.930017","article-title":"Liver cell-targeted delivery of therapeutic molecules","volume":"36","author":"Kang","year":"2016","journal-title":"Crit. Rev. Biotechnol."},{"issue":"3","key":"10.1016\/j.biopha.2019.109128_bib0025","doi-asserted-by":"crossref","DOI":"10.1177\/1073274817729240","article-title":"The role of diagnosis and treatment of underlying liver disease for the prognosis of primary liver cancer","volume":"24","author":"Shiani","year":"2017","journal-title":"Cancer Control"},{"issue":"6","key":"10.1016\/j.biopha.2019.109128_bib0030","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/hep.27406","article-title":"The global burden of liver disease: the major impact of China","volume":"60","author":"Wang","year":"2014","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.biopha.2019.109128_bib0035","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3390\/nu10070855","article-title":"Curcumin in liver diseases: a systematic review of the cellular mechanisms of oxidative stress and clinical perspective","volume":"10","author":"Farzaei","year":"2018","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib0040","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1586\/17474124.2016.1129274","article-title":"Pediatric liver diseases: current challenges and future perspectives","volume":"10","author":"Della Corte","year":"2016","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.biopha.2019.109128_bib0045","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","article-title":"The burden of liver disease in Europe: a review of available epidemiological data","volume":"58","author":"Blachier","year":"2013","journal-title":"J. Hepatol."},{"issue":"Pt B","key":"10.1016\/j.biopha.2019.109128_bib0050","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.fct.2016.08.034","article-title":"Hepatoprotective effect of quercetin: from chemistry to medicine","volume":"108","author":"Miltonprabu","year":"2017","journal-title":"Food Chem. Toxicol."},{"issue":"5","key":"10.1016\/j.biopha.2019.109128_bib0055","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1517\/17425240902936834","article-title":"Targeted delivery of drugs for liver fibrosis","volume":"6","author":"Li","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0060","doi-asserted-by":"crossref","first-page":"67","DOI":"10.18433\/J30C7D","article-title":"Nanotherapeutics to overcome conventional cancer chemotherapy limitations","volume":"14","author":"Chidambaram","year":"2011","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2019.109128_bib0065","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.nano.2015.12.381","article-title":"Drug delivery system targeting advanced hepatocellular carcinoma: current and future","volume":"12","author":"Zhang","year":"2016","journal-title":"Nanomedicine"},{"issue":"6","key":"10.1016\/j.biopha.2019.109128_bib0070","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1208\/s12249-015-0427-5","article-title":"Using PG-liposome-based system to enhance puerarin liver-targeted therapy for alcohol-induced liver disease","volume":"17","author":"Zhao","year":"2016","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"10.1016\/j.biopha.2019.109128_bib0075","doi-asserted-by":"crossref","DOI":"10.5582\/ddt.2013.v7.6.212","article-title":"Traditional Chinese medicine and related active compounds: a review of their role on hepatitis B virus infection","volume":"7","author":"Qi","year":"2013","journal-title":"Drug Discov. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2019.109128_bib0080","doi-asserted-by":"crossref","first-page":"327","DOI":"10.5582\/bst.2016.01110","article-title":"Advance in studies on traditional Chinese medicines to treat infection with the hepatitis B virus and hepatitis C virus","volume":"10","author":"Xia","year":"2016","journal-title":"Biosci. Trends"},{"issue":"12","key":"10.1016\/j.biopha.2019.109128_bib0085","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1111\/liv.12847","article-title":"Adjunctive traditional Chinese medicine therapy improves survival of liver cancer patients","volume":"35","author":"Liao","year":"2015","journal-title":"Liver Int."},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib0090","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11684-017-0512-0","article-title":"Effect of traditional Chinese medicine combined with Western therapy on primary hepatic carcinoma: a systematic review with meta-analysis","volume":"11","author":"Ma","year":"2017","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0095","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1038\/s41598-017-04351-y","article-title":"A systematic review and meta-analysis of traditional insect Chinese medicines combined chemotherapy for non-surgical hepatocellular carcinoma therapy","volume":"7","author":"Shi","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib0100","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3736\/jintegrmed2013021","article-title":"Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: a multicenter randomized controlled trial","volume":"11","author":"Zhai","year":"2013","journal-title":"J. Integr. Med."},{"issue":"10","key":"10.1016\/j.biopha.2019.109128_bib0105","doi-asserted-by":"crossref","first-page":"9715","DOI":"10.1007\/s11033-012-1836-0","article-title":"Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"39","author":"Shi","year":"2012","journal-title":"Mol. Biol. Rep."},{"issue":"47","key":"10.1016\/j.biopha.2019.109128_bib0110","doi-asserted-by":"crossref","first-page":"14436","DOI":"10.1073\/pnas.1515202112","article-title":"Nanotechnologies for biomedical science and translational medicine","volume":"112","author":"Heath","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.biopha.2019.109128_bib0115","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jsps.2016.04.010","article-title":"Preparation and application of functionalized nano drug carriers","volume":"24","author":"Gong","year":"2016","journal-title":"Saudi Pharm. J."},{"issue":"8","key":"10.1016\/j.biopha.2019.109128_bib0120","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.3109\/10717544.2015.1116025","article-title":"Advance of the application of nano-controlled release system in ophthalmic drug delivery","volume":"23","author":"Wang","year":"2016","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0125","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bbrc.2017.10.156","article-title":"Chitosan-coated doxorubicin nano-particles drug delivery system inhibits cell growth of liver cancer via p53\/PRC1 pathway","volume":"495","author":"Ye","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2019.109128_bib0130","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jconrel.2012.11.012","article-title":"Environmental pH-sensitive polymeric micelles for cancer diagnosis and targeted therapy","volume":"169","author":"Gao","year":"2013","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0135","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jhep.2014.03.009","article-title":"Traditional Chinese Medicine (TCM) for fibrotic liver disease: hope and hype","volume":"61","author":"Zhang","year":"2014","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.biopha.2019.109128_bib0140","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S2095-4964(14)60039-X","article-title":"Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities","volume":"12","author":"Zhao","year":"2014","journal-title":"J. Integr. Med."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2014.03.034","article-title":"Therapeutic effect of Soshiho-tang, a traditional herbal formula, on liver fibrosis or cirrhosis in animal models: a systematic review and meta-analysis","volume":"154","author":"Kim","year":"2014","journal-title":"J. Ethnopharmacol."},{"issue":"12","key":"10.1016\/j.biopha.2019.109128_bib0150","doi-asserted-by":"crossref","first-page":"28705","DOI":"10.3390\/ijms161226126","article-title":"Current status of herbal medicines in chronic liver disease therapy: the biological effects, molecular targets and future prospects","volume":"16","author":"Hong","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2019.109128_bib0155","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/ptr.6009","article-title":"Fuzheng Huayu capsule as an adjuvant treatment for HBV-related cirrhosis: a systematic review and meta-analysis","volume":"32","author":"Wang","year":"2018","journal-title":"Phytother. Res."},{"issue":"4","key":"10.1016\/j.biopha.2019.109128_bib0160","first-page":"404","article-title":"Modulation of IKKbeta\/NF-kappaB and TGF-beta1\/Smad via Fuzheng Huayu recipe involves in prevention of nutritional steatohepatitis and fibrosis in mice","volume":"18","author":"Wang","year":"2015","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"19","key":"10.1016\/j.biopha.2019.109128_bib0165","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.3748\/wjg.v11.i19.2892","article-title":"Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B","volume":"11","author":"Liu","year":"2005","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.biopha.2019.109128_bib0170","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.acthis.2018.06.006","article-title":"Pien Tze Huang ameliorates liver injury by inhibiting the PERK\/eIF2alpha signaling pathway in alcohol and high-fat diet rats","volume":"120","author":"Yang","year":"2018","journal-title":"Acta Histochem."},{"issue":"5","key":"10.1016\/j.biopha.2019.109128_bib0175","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.3892\/etm.2017.4174","article-title":"Pien Tze Huang Gan Bao ameliorates carbon tetrachloride-induced hepatic injury, oxidative stress and inflammation in rats","volume":"13","author":"Zhao","year":"2017","journal-title":"Exp. Ther. Med."},{"issue":"4","key":"10.1016\/j.biopha.2019.109128_bib0180","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1034\/j.1600-0773.2002.910406.x","article-title":"Pien Tze Huang protects the liver against carbon tetrachloride-induced damage","volume":"91","author":"Lee","year":"2002","journal-title":"Pharmacol. Toxicol."},{"issue":"6","key":"10.1016\/j.biopha.2019.109128_bib0185","first-page":"8132","article-title":"Pien Tze Huang inhibits the growth of hepatocellular carcinoma cells by upregulating miR-16 expression","volume":"14","author":"Qi","year":"2017","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.biopha.2019.109128_bib0190","first-page":"391","article-title":"[Pneumonitis induced by the herbal medicine Sho-saiko-to in Japan]","volume":"35","author":"Sato","year":"1997","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib0195","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1142\/S0192415X07004862","article-title":"Sho-saiko-to (Xiao-Chai-Hu-Tang) and crude saikosaponins inhibit hepatitis B virus in a stable HBV-producing cell line","volume":"35","author":"Chang","year":"2007","journal-title":"Am. J. Chin. Med."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0200","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jep.2011.04.008","article-title":"A single arm phase II study of a Far-Eastern traditional herbal formulation (sho-sai-ko-to or xiao-chai-hu-tang) in chronic hepatitis C patients","volume":"136","author":"Deng","year":"2011","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib0205","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1142\/S0192415X04001862","article-title":"Sho-saiko-to prevents liver fibrosis induced by bile duct ligation in rats","volume":"32","author":"Chen","year":"2004","journal-title":"Am. J. Chin. Med."},{"issue":"5","key":"10.1016\/j.biopha.2019.109128_bib0210","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/1097-0142(19950901)76:5<743::AID-CNCR2820760506>3.0.CO;2-V","article-title":"Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9)","volume":"76","author":"Oka","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2019.109128_bib0215","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fphar.2016.00016","article-title":"Selected topical agents used in traditional chinese medicine in the treatment of minor injuries- a review","volume":"7","author":"Leung","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0220","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1039\/C4FO00970C","article-title":"The anti-obesity effect of green tea polysaccharides, polyphenols and caffeine in rats fed with a high-fat diet","volume":"6","author":"Xu","year":"2015","journal-title":"Food Funct."},{"issue":"6","key":"10.1016\/j.biopha.2019.109128_bib0225","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrd2060","article-title":"Therapeutic potential of resveratrol: the in vivo evidence","volume":"5","author":"Baur","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0230","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s10753-011-9310-z","article-title":"Anti-inflammatory effect of resveratrol and polydatin by in vitro IL-17 modulation","volume":"35","author":"Lanzilli","year":"2012","journal-title":"Inflammation"},{"key":"10.1016\/j.biopha.2019.109128_bib0235","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/184241","article-title":"Antiviral activity of resveratrol against human and animal viruses","volume":"2015","author":"Abba","year":"2015","journal-title":"Adv. Virol."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0240","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/nyas.12160","article-title":"Resveratrol-based combinatorial strategies for cancer management","volume":"1290","author":"Singh","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2019.109128_bib0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183426","article-title":"Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1alpha expression and mitochondrial ROS production","volume":"12","author":"Ma","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.biopha.2019.109128_bib0250","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12272-010-0616-4","article-title":"Resveratrol inhibits dimethylnitrosamine-induced hepatic fibrosis in rats","volume":"33","author":"Lee","year":"2010","journal-title":"Arch. Pharm. Res."},{"issue":"7","key":"10.1016\/j.biopha.2019.109128_bib0255","first-page":"1198","article-title":"Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats","volume":"54","author":"Ali","year":"2016","journal-title":"Pharm. Biol."},{"issue":"9","key":"10.1016\/j.biopha.2019.109128_bib0260","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1016\/j.transproceed.2006.08.150","article-title":"The suppressive effect of resveratrol on protein kinase C theta in peripheral blood T lymphocytes in a rat liver transplantation model","volume":"38","author":"Wu","year":"2006","journal-title":"Transplant. Proc."},{"issue":"10","key":"10.1016\/j.biopha.2019.109128_bib0265","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.3748\/wjg.v9.i10.2341","article-title":"Effect of resveratrol on cell cycle proteins in murine transplantable liver cancer","volume":"9","author":"Yu","year":"2003","journal-title":"World J. Gastroenterol."},{"issue":"20","key":"10.1016\/j.biopha.2019.109128_bib0270","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.3748\/wjg.v10.i20.3048","article-title":"Effect of resveratrol and in combination with 5-FU on murine liver cancer","volume":"10","author":"Wu","year":"2004","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0275","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s12906-017-1956-0","article-title":"Resveratrol enhances anticancer effects of paclitaxel in HepG2 human liver cancer cells","volume":"17","author":"Jiang","year":"2017","journal-title":"BMC Complement. Altern. Med."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0280","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.3390\/ijms14011940","article-title":"Resveratrol down-regulates Myosin light chain kinase, induces apoptosis and inhibits diethylnitrosamine-induced liver tumorigenesis in rats","volume":"14","author":"Zhang","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2019.109128_bib0285","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0024-3205(03)00469-7","article-title":"Hypolipidemic action of dietary resveratrol, a phytoalexin in grapes and red wine, in hepatoma-bearing rats","volume":"73","author":"Miura","year":"2003","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.biopha.2019.109128_bib0290","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1006\/bbrc.1998.9916","article-title":"Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model","volume":"254","author":"Carbo","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2019.109128_bib0295","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1479-5876-7-22","article-title":"Caveolin-1 enhances resveratrol-mediated cytotoxicity and transport in a hepatocellular carcinoma model","volume":"7","author":"Yang","year":"2009","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib0300","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.etap.2009.12.006","article-title":"Quercetin protects rat liver against lead-induced oxidative stress and apoptosis","volume":"29","author":"Liu","year":"2010","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0305","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.tiv.2011.10.013","article-title":"Heme oxygenase-1 mediates the protective role of quercetin against ethanol-induced rat hepatocytes oxidative damage","volume":"26","author":"Liu","year":"2012","journal-title":"Toxicol. In Vitro"},{"issue":"12","key":"10.1016\/j.biopha.2019.109128_bib0310","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.fct.2006.07.012","article-title":"Protective effect of quercetin on experimental chronic cadmium nephrotoxicity in rats is based on its antioxidant properties","volume":"44","author":"Morales","year":"2006","journal-title":"Food Chem. Toxicol."},{"issue":"5","key":"10.1016\/j.biopha.2019.109128_bib0315","first-page":"582","article-title":"Quercetin potentially attenuates cadmium induced oxidative stress mediated cardiotoxicity and dyslipidemia in rats","volume":"17","author":"Milton Prabu","year":"2013","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2019.109128_bib0320","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.freeradbiomed.2016.11.037","article-title":"Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation","volume":"102","author":"Porras","year":"2017","journal-title":"Free Radic. Biol. Med."},{"issue":"9","key":"10.1016\/j.biopha.2019.109128_bib0325","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00204-011-0652-y","article-title":"Protective properties of quercetin against DNA damage and oxidative stress induced by methylmercury in rats","volume":"85","author":"Barcelos","year":"2011","journal-title":"Arch. Toxicol."},{"issue":"4","key":"10.1016\/j.biopha.2019.109128_bib0330","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12250-015-3584-5","article-title":"Inhibition of hepatitis B virus replication by quercetin in human hepatoma cell lines","volume":"30","author":"Cheng","year":"2015","journal-title":"Virol. Sin."},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib0335","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1111\/j.1365-2893.2011.01507.x","article-title":"Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity","volume":"19","author":"Bachmetov","year":"2012","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.biopha.2019.109128_bib0340","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4674918","article-title":"Quercetin reverses rat liver preneoplastic lesions induced by chemical carcinogenesis","volume":"2017","author":"Carrasco-Torres","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"12","key":"10.1016\/j.biopha.2019.109128_bib0345","article-title":"Quercetin potentiates doxorubicin mediated antitumor effects against liver cancer through p53\/Bcl-xl","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib0350","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/19390211.2015.1008611","article-title":"Mitigation of systemic oxidative stress by curcuminoids in osteoarthritis: results of a randomized controlled trial","volume":"13","author":"Panahi","year":"2016","journal-title":"J. Diet. Suppl."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0355","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/19390211.2014.952865","article-title":"Effects of curcuminoids-piperine combination on systemic oxidative stress, clinical symptoms and quality of life in subjects with chronic pulmonary complications due to sulfur mustard: a randomized controlled trial","volume":"13","author":"Panahi","year":"2014","journal-title":"J. Diet. Suppl."},{"issue":"1-2","key":"10.1016\/j.biopha.2019.109128_bib0360","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1383-5718(02)00016-5","article-title":"Antimutagenic potential of curcumin on chromosomal aberrations in Wistar rats","volume":"515","author":"Shukla","year":"2002","journal-title":"Mutat. Res."},{"issue":"6","key":"10.1016\/j.biopha.2019.109128_bib0365","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.clnu.2014.12.019","article-title":"Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: a randomized controlled trial and an updated meta-analysis","volume":"34","author":"Panahi","year":"2015","journal-title":"Clin. Nutr."},{"issue":"15","key":"10.1016\/j.biopha.2019.109128_bib0370","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1042\/CS20160935","article-title":"Curcumin mediates anticancer effects by modulating multiple cell signaling pathways","volume":"131","author":"Kunnumakkara","year":"2017","journal-title":"Clin. Sci. (Lond.)"},{"issue":"11","key":"10.1016\/j.biopha.2019.109128_bib0375","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/ptr.5174","article-title":"Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial","volume":"28","author":"Panahi","year":"2014","journal-title":"Phytother. Res."},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib0380","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.dyepig.2004.05.008","article-title":"Antimicrobial activity of wool fabric treated with curcumin","volume":"64","author":"Han","year":"2005","journal-title":"Dye. Pigment."},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib0385","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jnutbio.2013.09.013","article-title":"Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial","volume":"25","author":"Chuengsamarn","year":"2014","journal-title":"J. Nutr. Biochem."},{"issue":"6","key":"10.1016\/j.biopha.2019.109128_bib0390","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/bcpt.12212","article-title":"Low-density lipoprotein is a potential target for curcumin: novel mechanistic insights","volume":"114","author":"Sahebkar","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0395","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ptr.5211","article-title":"Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder","volume":"29","author":"Panahi","year":"2015","journal-title":"Phytother. Res."},{"issue":"6","key":"10.1016\/j.biopha.2019.109128_bib0400","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.phymed.2011.12.006","article-title":"Curcumin prevents chronic alcohol-induced liver disease involving decreasing ROS generation and enhancing antioxidative capacity","volume":"19","author":"Rong","year":"2012","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2019.109128_bib0405","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.intimp.2017.01.016","article-title":"Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-kappaB translocation","volume":"44","author":"Afrin","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2019.109128_bib0410","doi-asserted-by":"crossref","first-page":"607","DOI":"10.5604\/01.3001.0010.0307","article-title":"Hepatoprotective effect of curcumin on hepatocellular carcinoma through autophagic and apoptic pathways","volume":"16","author":"Elmansi","year":"2017","journal-title":"Ann. Hepatol."},{"issue":"4","key":"10.1016\/j.biopha.2019.109128_bib0415","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-0043-100019","article-title":"Efficacy and safety of phytosomal curcumin in non-alcoholic fatty liver disease: a randomized controlled trial","volume":"67","author":"Panahi","year":"2017","journal-title":"Drug Res. (Stuttg.)"},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib0420","first-page":"895","article-title":"Curcumin inhibits liver cancer by inhibiting DAMP molecule HSP70 and TLR4 signaling","volume":"40","author":"Ren","year":"2018","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2019.109128_bib0425","first-page":"3650","article-title":"Curcumin inhibits the growth of liver cancer stem cells through the phosphatidylinositol 3-kinase\/protein kinase B\/mammalian target of rapamycin signaling pathway","volume":"15","author":"Wang","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"10","key":"10.1016\/j.biopha.2019.109128_bib0430","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.bcp.2012.07.018","article-title":"Berberine: new perspectives for old remedies","volume":"84","author":"Tillhon","year":"2012","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.biopha.2019.109128_bib0435","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/ptr.2399","article-title":"Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine","volume":"22","author":"Imanshahidi","year":"2008","journal-title":"Phytother. Res."},{"issue":"4","key":"10.1016\/j.biopha.2019.109128_bib0440","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3109\/10641963.2014.972560","article-title":"Anti-hypertensive and renoprotective effects of berberine in spontaneously hypertensive rats","volume":"37","author":"Guo","year":"2015","journal-title":"Clin. Exp. Hypertens."},{"issue":"4","key":"10.1016\/j.biopha.2019.109128_bib0445","doi-asserted-by":"crossref","first-page":"415","DOI":"10.4196\/kjpp.2016.20.4.415","article-title":"Activating transcription factor-3 induction is involved in the anti-inflammatory action of berberine in RAW264.7 murine macrophages","volume":"20","author":"Bae","year":"2016","journal-title":"Korean J. Physiol. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2019.109128_bib0450","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1556\/APhysiol.99.2012.3.8","article-title":"Hypoxia-inducible factor 1 mediates the anti-apoptosis of berberine in neurons during hypoxia\/ischemia","volume":"99","author":"Zhang","year":"2012","journal-title":"Acta Physiol. Hung."},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib0455","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/187153008784534330","article-title":"Traditional chinese medicine in treatment of metabolic syndrome","volume":"8","author":"Yin","year":"2008","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"issue":"3","key":"10.1016\/j.biopha.2019.109128_bib0460","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ptr.890","article-title":"The potential of alkaloids in drug discovery","volume":"15","author":"Cordell","year":"2001","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biopha.2019.109128_bib0465","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejphar.2017.11.013","article-title":"Berberine protects acute liver failure in mice through inhibiting inflammation and mitochondria-dependent apoptosis","volume":"819","author":"Xu","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2019.109128_bib0470","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.fct.2014.10.005","article-title":"Berberine protects liver from ethanol-induced oxidative stress and steatosis in mice","volume":"74","author":"Zhang","year":"2014","journal-title":"Food Chem. Toxicol."},{"issue":"8","key":"10.1016\/j.biopha.2019.109128_bib0475","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134172","article-title":"Efficacy of berberine in patients with non-alcoholic fatty liver disease","volume":"10","author":"Yan","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib0480","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3892\/mmr.2013.1506","article-title":"Berberine induces selective apoptosis through the AMPKmediated mitochondrial\/caspase pathway in hepatocellular carcinoma","volume":"8","author":"Yang","year":"2013","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib0485","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3727\/096504016X14742891049073","article-title":"Induction of apoptosis by berberine in hepatocellular carcinoma HepG2 cells via downregulation of NF-kappaB","volume":"25","author":"Li","year":"2017","journal-title":"Oncol. Res."},{"issue":"6","key":"10.1016\/j.biopha.2019.109128_bib0490","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/cbdd.12124","article-title":"Calmodulin as a potential target by which berberine induces cell cycle arrest in human hepatoma Bel7402 cells","volume":"81","author":"Ma","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"issue":"6","key":"10.1016\/j.biopha.2019.109128_bib0495","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.3892\/mmr.2014.2608","article-title":"Berberine sensitizes rapamycinmediated human hepatoma cell death in vitro","volume":"10","author":"Guo","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2019.109128_bib0500","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/756519","article-title":"The effect of sodium tanshinone IIA sulfate and simvastatin on elevated serum levels of inflammatory markers in patients with coronary heart disease: a study protocol for a randomized controlled trial","volume":"2013","author":"Shang","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"4","key":"10.1016\/j.biopha.2019.109128_bib0505","first-page":"2931","article-title":"Tanshinone IIA inhibits cell proliferation and tumor growth by downregulating STAT3 in human gastric cancer","volume":"16","author":"Zhang","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"5","key":"10.1016\/j.biopha.2019.109128_bib0510","first-page":"4639","article-title":"Effect of tanshinone IIA on oxidative stress and apoptosis in a rat model of fatty liver","volume":"14","author":"Yang","year":"2017","journal-title":"Exp. Ther. Med."},{"issue":"5","key":"10.1016\/j.biopha.2019.109128_bib0515","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s12272-001-1209-2","article-title":"Effects of tanshinone IIA on the hepatotoxicity and gene expression involved in alcoholic liver disease","volume":"31","author":"Yin","year":"2008","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.biopha.2019.109128_bib0520","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.biopha.2017.03.022","article-title":"Pre-conditioning with tanshinone IIA attenuates the ischemia\/reperfusion injury caused by liver grafts via regulation of HMGB1 in rat Kupffer cells","volume":"89","author":"Li","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2019.109128_bib0525","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejphar.2016.11.046","article-title":"Tanshinone IIA induced cell death via miR30b-p53-PTPN11\/SHP2 signaling pathway in human hepatocellular carcinoma cells","volume":"796","author":"Ren","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2019.109128_bib0530","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejphar.2015.07.047","article-title":"Inhibition of cytochrome P450 2J2 by tanshinone IIA induces apoptotic cell death in hepatocellular carcinoma HepG2 cells","volume":"764","author":"Jeon","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2019.109128_bib0535","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1756-8722-5-69","article-title":"Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization","volume":"5","author":"Wang","year":"2012","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib0540","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11373-005-1572-8","article-title":"Protective effects of baicalein on tert-butyl hydroperoxide-induced hepatic toxicity in rat hepatocytes","volume":"12","author":"Hwang","year":"2005","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.biopha.2019.109128_bib0545","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12906-015-0682-8","article-title":"Baicalein reduces the occurrence of cirrhotic endotoxemia by reducing intestinal mucosal apoptosis","volume":"15","author":"Liu","year":"2015","journal-title":"BMC Complement. Altern. Med."},{"issue":"3","key":"10.1016\/j.biopha.2019.109128_bib0550","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.cbi.2010.09.008","article-title":"Baicalein inhibits nuclear factor-kappaB and apoptosis via c-FLIP and MAPK in D-GalN\/LPS induced acute liver failure in murine models","volume":"188","author":"Wu","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.biopha.2019.109128_bib0555","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.intimp.2017.12.002","article-title":"Baicalein improves liver inflammation in diabetic db\/db mice by regulating HMGB1\/TLR4\/NF-kappaB signaling pathway","volume":"55","author":"Yin","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2019.109128_bib0560","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1055\/s-2002-26760","article-title":"Effect of baicalein on apoptosis of the human Hep G2 cell line was induced by mitochondrial dysfunction","volume":"68","author":"Chang","year":"2002","journal-title":"Planta Med."},{"key":"10.1016\/j.biopha.2019.109128_bib0565","article-title":"Baicalein induces apoptosis and autophagy via endoplasmic reticulum stress in hepatocellular carcinoma cells","volume":"2014","author":"Wang","year":"2014","journal-title":"Biomed Res. Int."},{"issue":"3","key":"10.1016\/j.biopha.2019.109128_bib0570","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.taap.2011.07.008","article-title":"Baicalein inhibits the migration and invasive properties of human hepatoma cells","volume":"255","author":"Chiu","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"9","key":"10.1016\/j.biopha.2019.109128_bib0575","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/ptr.5135","article-title":"Anticancer effects of baicalein on hepatocellular carcinoma cells","volume":"28","author":"Zheng","year":"2014","journal-title":"Phytother. Res."},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib0580","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1207\/S15327914NC382_19","article-title":"Baicalein, a novel apoptotic agent for hepatoma cell lines: a potential medicine for hepatoma","volume":"38","author":"Chen","year":"2000","journal-title":"Nutr. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2019.109128_bib0585","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/ptr.5298","article-title":"Baicalein triggers autophagy and inhibits the protein kinase B\/Mammalian target of rapamycin pathway in hepatocellular carcinoma HepG2 cells","volume":"29","author":"Wang","year":"2015","journal-title":"Phytother. Res."},{"issue":"9","key":"10.1016\/j.biopha.2019.109128_bib0590","article-title":"Baicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via down-regulation of the ERK pathway","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"issue":"91","key":"10.1016\/j.biopha.2019.109128_bib0595","doi-asserted-by":"crossref","first-page":"36331","DOI":"10.18632\/oncotarget.26348","article-title":"Antitumor properties of Salvianolic acid B against triple-negative and hormone receptor-positive breast cancer cells via ceramide-mediated apoptosis","volume":"9","author":"Sha","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2019.109128_bib0600","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.brainres.2017.11.027","article-title":"Mechanism of salvianolic acid B neuroprotection against ischemia\/reperfusion induced cerebral injury","volume":"1679","author":"Fan","year":"2018","journal-title":"Brain Res."},{"issue":"8","key":"10.1016\/j.biopha.2019.109128_bib0605","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135435","article-title":"Combined salvianolic acid B and ginsenoside Rg1 exerts cardioprotection against ischemia\/reperfusion injury in rats","volume":"10","author":"Deng","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2019.109128_bib0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2016.12.010","article-title":"Salvianolic acid B protects against chronic alcoholic liver injury via SIRT1-mediated inhibition of CRP and ChREBP in rats","volume":"267","author":"Zhang","year":"2017","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.biopha.2019.109128_bib0615","doi-asserted-by":"crossref","first-page":"16013","DOI":"10.1038\/srep16013","article-title":"Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease","volume":"5","author":"Zeng","year":"2015","journal-title":"Sci. Rep."},{"issue":"35","key":"10.1016\/j.biopha.2019.109128_bib0620","doi-asserted-by":"crossref","first-page":"10104","DOI":"10.3748\/wjg.v21.i35.10104","article-title":"Effects of salvianolic acid B on liver mitochondria of rats with nonalcoholic steatohepatitis","volume":"21","author":"Wang","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.biopha.2019.109128_bib0625","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3748\/wjg.v8.i4.679","article-title":"Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B","volume":"8","author":"Liu","year":"2002","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.biopha.2019.109128_bib0630","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jep.2012.09.048","article-title":"Inhibitory effects of salvianolic acid B on CCl(4)-induced hepatic fibrosis through regulating NF-kappaB\/IkappaBalpha signaling","volume":"144","author":"Wang","year":"2012","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib0635","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.toxlet.2014.04.011","article-title":"Salvianolic acid B protects against acute ethanol-induced liver injury through SIRT1-mediated deacetylation of p53 in rats","volume":"228","author":"Li","year":"2014","journal-title":"Toxicol. Lett."},{"issue":"6","key":"10.1016\/j.biopha.2019.109128_bib0640","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.3892\/ijo.2016.3748","article-title":"AKT\/mTOR signaling pathway is involved in salvianolic acid B-induced autophagy and apoptosis in hepatocellular carcinoma cells","volume":"49","author":"Gong","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2019.109128_bib0645","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S1499-3872(11)60085-4","article-title":"Salvianolic acid B modulates the expression of drug-metabolizing enzymes in HepG2 cells","volume":"10","author":"Wang","year":"2011","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"issue":"9","key":"10.1016\/j.biopha.2019.109128_bib0650","first-page":"691","article-title":"[Comparison of the anti-arrhythmic effects of matrine and berbamine with amiodarone and RP58866]","volume":"39","author":"Xu","year":"2004","journal-title":"Yao Xue Xue Bao"},{"key":"10.1016\/j.biopha.2019.109128_bib0655","first-page":"41","article-title":"Studies on site of analgesic action of matrine and its mechanism","volume":"32","author":"Luo","year":"2001","journal-title":"Chin. Tradit. Herb. Drugs"},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib0660","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1443-9573.2005.00201.x","article-title":"Synergistic effects of matrine and 5-fluorouracil on tumor growth of the implanted gastric cancer in nude mice","volume":"6","author":"Hu","year":"2005","journal-title":"Chin. J. Dig. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2019.109128_bib0665","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1055\/s-2006-931534","article-title":"Matrine-induced apoptosis in leukemia U937 cells: involvement of caspases activation and MAPK-independent pathways","volume":"72","author":"Liu","year":"2006","journal-title":"Planta Med."},{"issue":"3","key":"10.1016\/j.biopha.2019.109128_bib0670","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1142\/S0192415X03001107","article-title":"Radix Sophorae flavescentis for chronic hepatitis B: a systematic review of randomized trials","volume":"31","author":"Liu","year":"2003","journal-title":"Am. J. Chin. Med."},{"issue":"5","key":"10.1016\/j.biopha.2019.109128_bib0675","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S1995-7645(14)60062-6","article-title":"Effect of matrine on transforming growth factor \u03b21 and hepatocyte growth factor in rat liver fibrosis model","volume":"7","author":"Yu","year":"2014","journal-title":"Asian Pac. J. Trop. Med."},{"issue":"8","key":"10.1016\/j.biopha.2019.109128_bib0680","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00595-010-4423-9","article-title":"Matrine attenuates endotoxin-induced acute liver injury after hepatic ischemia\/reperfusion in rats","volume":"41","author":"Zhang","year":"2011","journal-title":"Surg. Today"},{"issue":"17","key":"10.1016\/j.biopha.2019.109128_bib0685","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1111\/bph.13209","article-title":"Identification of matrine as a promising novel drug for hepatic steatosis and glucose intolerance with HSP72 as an upstream target","volume":"172","author":"Zeng","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2019.109128_bib0690","first-page":"183","article-title":"Antifibrotic effects of matrine on in vitro and in vivo models of liver fibrosis in rats","volume":"22","author":"Zhang","year":"2001","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0695","first-page":"911","article-title":"Matrine inhibits the invasive and migratory properties of human hepatocellular carcinoma by regulating epithelialmesenchymal transition","volume":"18","author":"Wang","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0700","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3892\/mmr.2016.5999","article-title":"Matrineinduced apoptosis in Hep3B cells via the inhibition of MDM2","volume":"15","author":"Zhou","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"34","key":"10.1016\/j.biopha.2019.109128_bib0705","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.3748\/wjg.v16.i34.4281","article-title":"Antitumor effect of matrine in human hepatoma G2 cells by inducing apoptosis and autophagy","volume":"16","author":"Zhang","year":"2010","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib0710","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3892\/ijo.2015.3023","article-title":"Matrine-induced autophagy regulated by p53 through AMP-activated protein kinase in human hepatoma cells","volume":"47","author":"Xie","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib0715","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1096\/fj.201700602R","article-title":"Silybin inhibits NLRP3 inflammasome assembly through the NAD(+)\/SIRT2 pathway in mice with nonalcoholic fatty liver disease","volume":"32","author":"Zhang","year":"2018","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.biopha.2019.109128_bib0720","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.jvir.2010.05.028","article-title":"Experimental evaluation of inhibitory effect of 10-hydroxycamptothecin on hypoxia-inducible factor-1alpha expression and angiogenesis in liver tumors after transcatheter arterial embolization","volume":"21","author":"Liang","year":"2010","journal-title":"J. Vasc. Interv. Radiol."},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib0725","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.canlet.2007.06.014","article-title":"Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes","volume":"256","author":"Yang","year":"2007","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.biopha.2019.109128_bib0730","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1248\/bpb.b18-00132","article-title":"Ginsenoside Rg1 protects against non-alcoholic fatty liver disease by ameliorating lipid peroxidation, endoplasmic reticulum stress, and inflammasome activation","volume":"41","author":"Xu","year":"2018","journal-title":"Biol. Pharm. Bull."},{"issue":"4","key":"10.1016\/j.biopha.2019.109128_bib0735","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/biof.1432","article-title":"Ginsenoside Rg1 ameliorates liver fibrosis via suppressing epithelial to mesenchymal transition and reactive oxygen species production in vitro and in vivo","volume":"44","author":"Wei","year":"2018","journal-title":"Biofactors"},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib0740","first-page":"899","article-title":"Ginsenoside Rg1 inhibits inflammatory responses via modulation of the nuclear factorkappaB pathway and inhibition of inflammasome activation in alcoholic hepatitis","volume":"41","author":"Li","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2019.109128_bib0745","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2017.04.021","article-title":"Protective effects of glycyrrhizic acid against non-alcoholic fatty liver disease in mice","volume":"806","author":"Sun","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"17","key":"10.1016\/j.biopha.2019.109128_bib0750","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.3748\/wjg.v21.i17.5271","article-title":"Glycyrrhizic acid inhibits apoptosis and fibrosis in carbon-tetrachloride-induced rat liver injury","volume":"21","author":"Liang","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2019.109128_bib0755","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.biopha.2017.08.071","article-title":"Effect of two andrographolide derivatives on cellular and rodent models of non-alcoholic fatty liver disease","volume":"95","author":"Toppo","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2019.109128_bib0760","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2018.01.007","article-title":"Natural product andrographolide alleviated APAP-induced liver fibrosis by activating Nrf2 antioxidant pathway","volume":"396\u2013397","author":"Yan","year":"2018","journal-title":"Toxicology"},{"issue":"3","key":"10.1016\/j.biopha.2019.109128_bib0765","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1530\/JOE-17-0233","article-title":"Ginsenoside Rg3 ameliorated HFD-induced hepatic steatosis through downregulation of STAT5-PPARgamma","volume":"235","author":"Lee","year":"2017","journal-title":"J. Endocrinol."},{"issue":"3","key":"10.1016\/j.biopha.2019.109128_bib0770","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/hep.29177","article-title":"Ginsenoside Rg3 restores hepatitis C virus-induced aberrant mitochondrial dynamics and inhibits virus propagation","volume":"66","author":"Kim","year":"2017","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib0775","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3892\/mmr.2013.1512","article-title":"Oxymatrine ameliorates non-alcoholic fatty liver disease in rats through peroxisome proliferator-activated receptor-alpha activation","volume":"8","author":"Shi","year":"2013","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2019.109128_bib0780","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1194\/jlr.M035907","article-title":"Ginsenoside Rb1 reduces fatty liver by activating AMP-activated protein kinase in obese rats","volume":"54","author":"Shen","year":"2013","journal-title":"J. Lipid Res."},{"issue":"10","key":"10.1016\/j.biopha.2019.109128_bib0785","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1089\/jmf.2010.1485","article-title":"Ginsenoside Rb1 inhibits cell activation and liver fibrosis in rat hepatic stellate cells","volume":"14","author":"Lo","year":"2011","journal-title":"J. Med. Food"},{"issue":"3","key":"10.1016\/j.biopha.2019.109128_bib0790","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1159\/000447820","article-title":"Baicalin attenuates alcoholic liver injury through modulation of hepatic oxidative stress, inflammation and sonic hedgehog pathway in rats","volume":"39","author":"Wang","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"issue":"9","key":"10.1016\/j.biopha.2019.109128_bib0795","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.bcp.2013.02.007","article-title":"Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway","volume":"85","author":"Quan","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib0800","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.intimp.2013.06.012","article-title":"Betulinic acid and betulin ameliorate acute ethanol-induced fatty liver via TLR4 and STAT3 in vivo and in vitro","volume":"17","author":"Wan","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2019.109128_bib0805","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.phrs.2018.03.017","article-title":"Dioscin alleviates non-alcoholic fatty liver disease through adjusting lipid metabolism via SIRT1\/AMPK signaling pathway","volume":"131","author":"Yao","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2019.109128_bib0810","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.intimp.2017.06.013","article-title":"Wogonin attenuates inflammation by activating PPAR-gamma in alcoholic liver disease","volume":"50","author":"Li","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2019.109128_bib0815","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.biopha.2017.04.125","article-title":"Wogonin mitigates nonalcoholic fatty liver disease via enhancing PPARalpha\/AdipoR2, in vivo and in vitro","volume":"91","author":"Chen","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0820","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.antiviral.2007.01.002","article-title":"Anti-hepatitis B virus activity of wogonin in vitro and in vivo","volume":"74","author":"Guo","year":"2007","journal-title":"Antiviral Res."},{"issue":"4","key":"10.1016\/j.biopha.2019.109128_bib0825","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.bbrc.2016.11.101","article-title":"Luteolin improves non-alcoholic fatty liver disease in db\/db mice by inhibition of liver X receptor activation to down-regulate expression of sterol regulatory element binding protein 1c","volume":"482","author":"Yin","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.biopha.2019.109128_bib0830","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3945\/jn.114.193128","article-title":"Luteolin alleviates alcoholic liver disease induced by chronic and binge ethanol feeding in mice","volume":"144","author":"Liu","year":"2014","journal-title":"J. Nutr."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0835","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.intimp.2015.05.009","article-title":"Protective effects of luteolin against acetaminophen-induced acute liver failure in mouse","volume":"27","author":"Tai","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2019.109128_bib0840","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1111\/liv.12638","article-title":"Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT\/mTOR\/p70S6K and TGFbeta\/Smad signalling pathways","volume":"35","author":"Li","year":"2015","journal-title":"Liver Int."},{"issue":"4","key":"10.1016\/j.biopha.2019.109128_bib0845","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1007\/s13277-013-1396-5","article-title":"Anti-hepatoma cells function of luteolin through inducing apoptosis and cell cycle arrest","volume":"35","author":"Ding","year":"2014","journal-title":"Tumour Biol."},{"issue":"23","key":"10.1016\/j.biopha.2019.109128_bib0850","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.1021\/acs.jafc.8b01691","article-title":"Genistein ameliorates non-alcoholic fatty liver disease by targeting the thromboxane A2 pathway","volume":"66","author":"Wang","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2019.109128_bib0855","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cbi.2016.11.022","article-title":"Genistein attenuates D-GalN induced liver fibrosis\/chronic liver damage in rats by blocking the TGF-beta\/Smad signaling pathways","volume":"261","author":"Ganai","year":"2017","journal-title":"Chem. Biol. Interact."},{"issue":"10","key":"10.1016\/j.biopha.2019.109128_bib0860","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/bjc.2017.323","article-title":"Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death","volume":"117","author":"Li","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2019.109128_bib0865","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejphar.2016.04.042","article-title":"Isorhamnetin attenuates liver fibrosis by inhibiting TGF-beta\/Smad signaling and relieving oxidative stress","volume":"783","author":"Yang","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2019.109128_bib0870","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.phrs.2006.04.007","article-title":"In vitro anti-tumor activity of isorhamnetin isolated from Hippophae rhamnoides L. against BEL-7402 cells","volume":"54","author":"Teng","year":"2006","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2019.109128_bib0875","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.lfs.2017.08.019","article-title":"Naringin attenuates thioacetamide-induced liver fibrosis in rats through modulation of the PI3K\/Akt pathway","volume":"187","author":"El-Mihi","year":"2017","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2019.109128_bib0880","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.lfs.2018.07.031","article-title":"Naringin attenuates alcoholic liver injury by reducing lipid accumulation and oxidative stress","volume":"216","author":"Zhou","year":"2019","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.biopha.2019.109128_bib0885","first-page":"3289","article-title":"Induction of human hepatocellular carcinoma HepG2 cell apoptosis by Naringin","volume":"17","author":"Banjerdpongchai","year":"2016","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2019.109128_bib0890","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejphar.2006.09.011","article-title":"Bifendate treatment attenuates hepatic steatosis in cholesterol\/bile salt- and high-fat diet-induced hypercholesterolemia in mice","volume":"552","author":"Pan","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2019.109128_bib0895","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.intimp.2017.05.026","article-title":"Rutin exhibits hepatoprotective effects in a mouse model of non-alcoholic fatty liver disease by reducing hepatic lipid levels and mitigating lipid-induced oxidative injuries","volume":"49","author":"Liu","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2019.109128_bib0900","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tox.2017.05.012","article-title":"Glycyrrhizin and glycyrrhetinic acid inhibits alpha-naphthyl isothiocyanate-induced liver injury and bile acid cycle disruption","volume":"386","author":"Wang","year":"2017","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib0905","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3892\/or.2017.5775","article-title":"Norcantharidin inhibits IL-6-induced epithelialmesenchymal transition via the JAK2\/STAT3\/TWIST signaling pathway in hepatocellular carcinoma cells","volume":"38","author":"Gao","year":"2017","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2019.109128_bib0910","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/08820139.2015.1137935","article-title":"Trillin reduces liver chronic inflammation and fibrosis in Carbon Tetrachloride (CCl4) induced liver injury in mice","volume":"45","author":"Tan","year":"2016","journal-title":"Immunol. Invest."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0915","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1142\/S0192415X10007695","article-title":"Curcumin and saikosaponin a inhibit chemical-induced liver inflammation and fibrosis in rats","volume":"38","author":"Wu","year":"2010","journal-title":"Am. J. Chin. Med."},{"issue":"38","key":"10.1016\/j.biopha.2019.109128_bib0920","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.1021\/acs.jafc.6b02907","article-title":"Protective effects of genistein and Puerarin against chronic alcohol-induced liver injury in mice via antioxidant, anti-inflammatory, and anti-apoptotic mechanisms","volume":"64","author":"Zhao","year":"2016","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2019.109128_bib0925","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2748367","article-title":"Shikonin attenuates concanavalin a-induced acute liver injury in mice via inhibition of the JNK pathway","volume":"2016","author":"Liu","year":"2016","journal-title":"Mediators Inflamm."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0930","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbrc.2017.08.141","article-title":"Apigenin inhibits d-galactosamine\/LPS-induced liver injury through upregulation of hepatic Nrf-2 and PPARgamma expressions in mice","volume":"493","author":"Zhou","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.biopha.2019.109128_bib0935","doi-asserted-by":"crossref","first-page":"1600392","DOI":"10.1002\/mnfr.201600392","article-title":"The common dietary flavonoid myricetin attenuates liver fibrosis in carbon tetrachloride treated mice","volume":"61","author":"Geng","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0940","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/aps.2017.129","article-title":"Osthole prevents acetaminophen-induced liver injury in mice","volume":"39","author":"Cai","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.biopha.2019.109128_bib0945","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/mnfr.200500022","article-title":"Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications","volume":"49","author":"de la Lastra","year":"2005","journal-title":"Mol. Nutr. Food Res."},{"issue":"24","key":"10.1016\/j.biopha.2019.109128_bib0950","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/S0024-3205(97)00230-0","article-title":"Molecular mechanisms in the antiproliferative action of quercetin","volume":"60","author":"Csokay","year":"1997","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.biopha.2019.109128_bib0955","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185999","article-title":"Nanoparticle curcumin ameliorates experimental colitis via modulation of gut microbiota and induction of regulatory T cells","volume":"12","author":"Ohno","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0960","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1080\/10717544.2017.1321062","article-title":"PEG-lipid-PLGA hybrid nanoparticles loaded with berberine-phospholipid complex to facilitate the oral delivery efficiency","volume":"24","author":"Yu","year":"2017","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0965","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1015860525341","article-title":"Monoclonal antibodies as magic bullets","volume":"05","author":"Brodsky","year":"1988","journal-title":"Pharm. Res."},{"issue":"9","key":"10.1016\/j.biopha.2019.109128_bib0970","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1211\/jpp.61.09.0004","article-title":"Mannose 6-phosphate-modified bovine serum albumin nanoparticles for controlled and targeted delivery of sodium ferulate for treatment of hepatic fibrosis","volume":"61","author":"Li","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.biopha.2019.109128_bib0975","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejps.2016.09.036","article-title":"Synthesis, characterization and liver targeting evaluation of self-assembled hyaluronic acid nanoparticles functionalized with glycyrrhetinic acid","volume":"96","author":"Wang","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0980","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijpharm.2017.03.081","article-title":"A novel serum-stable liver targeted cytotoxic system using valerate-conjugated chitosan nanoparticles surface decorated with glycyrrhizin","volume":"525","author":"El-Marakby","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0985","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10717544.2017.1399301","article-title":"Enhanced efficacy of curcumin with phosphatidylserine-decorated nanoparticles in the treatment of hepatic fibrosis","volume":"25","author":"Wang","year":"2018","journal-title":"Drug Deliv."},{"issue":"6","key":"10.1016\/j.biopha.2019.109128_bib0990","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/tox.21940","article-title":"Effects of nanoparticle-encapsulated curcumin on arsenic-induced liver toxicity in rats","volume":"30","author":"Sankar","year":"2015","journal-title":"Environ. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib0995","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0169-409X(95)00043-7","article-title":"Mechanisms of splenic clearance of blood cells and particles: towards development of new splenotropic agents","volume":"17","author":"Moghimi","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib1000","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0169-409X(95)00041-5","article-title":"Exploiting bone marrow microvascular structure for drug delivery and future therapies","volume":"17","author":"Moghimi","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1-2","key":"10.1016\/j.biopha.2019.109128_bib1005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0378-5173(02)00267-3","article-title":"Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles","volume":"243","author":"Banerjee","year":"2002","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib1010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/01926230590881826","article-title":"New insights into functional aspects of liver morphology","volume":"33","author":"Malarkey","year":"2005","journal-title":"Toxicol. Pathol."},{"issue":"19","key":"10.1016\/j.biopha.2019.109128_bib1015","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.2174\/092986712800784720","article-title":"Drug targeting to cancer by nanoparticles surface functionalized with special biomolecules","volume":"19","author":"Holgado","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2019.109128_bib1020","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-2836(64)80115-7","article-title":"Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope","volume":"8","author":"Bangham","year":"1964","journal-title":"J. Mol. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib1025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/1567201813666160115125756","article-title":"Potential of liposomes for enhancement of oral drug absorption","volume":"14","author":"Daeihamed","year":"2017","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.biopha.2019.109128_bib1030","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2147\/IJN.S68861","article-title":"Liposomes as nanomedical devices","volume":"10","author":"Bozzuto","year":"2015","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib1035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1248\/bpb.b16-00624","article-title":"Liposomal delivery systems: design optimization and current applications","volume":"40","author":"Abu Lila","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.biopha.2019.109128_bib1040","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.msec.2014.04.049","article-title":"Drug delivery vehicles on a nano-engineering perspective","volume":"41","author":"Felice","year":"2014","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"3","key":"10.1016\/j.biopha.2019.109128_bib1045","doi-asserted-by":"crossref","first-page":"401","DOI":"10.18433\/J3CP55","article-title":"Liposomal drug delivery: a versatile platform for challenging clinical applications","volume":"17","author":"Madni","year":"2014","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2019.109128_bib1050","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/10717544.2011.577110","article-title":"Hepatoprotective and neuroprotective activity of liposomal quercetin in combating chronic arsenic induced oxidative damage in liver and brain of rats","volume":"18","author":"Ghosh","year":"2011","journal-title":"Drug Deliv."},{"issue":"3","key":"10.1016\/j.biopha.2019.109128_bib1055","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1124\/jpet.106.114215","article-title":"Hepatoprotective activity of liposomal flavonoid against arsenite-induced liver fibrosis","volume":"320","author":"Mandal","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"8","key":"10.1016\/j.biopha.2019.109128_bib1060","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1590\/1414-431x20143704","article-title":"Inhibitory effect of liposomal quercetin on acute hepatitis and hepatic fibrosis induced by concanavalin A","volume":"47","author":"Wan","year":"2014","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"10","key":"10.1016\/j.biopha.2019.109128_bib1065","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1158\/1078-0432.CCR-05-2365","article-title":"Liposomal quercetin efficiently suppresses growth of solid tumors in murine models","volume":"12","author":"Yuan","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2019.109128_bib1070","first-page":"3623","article-title":"Preparation, pharmacokinetics and biodistribution of baicalin-loaded liposomes","volume":"9","author":"Wei","year":"2014","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib1075","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijpharm.2018.05.007","article-title":"Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma","volume":"545","author":"Cheng","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.biopha.2019.109128_bib1080","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2174\/1389200219666171207120643","article-title":"Long circulating polymeric nanoparticles for gene\/drug delivery","volume":"19","author":"Hu","year":"2018","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.biopha.2019.109128_bib1085","article-title":"Biodegradable polymeric nanoparticles as the delivery carrier for drug","volume":"13","author":"Zhao","year":"2015","journal-title":"Curr. Drug Deliv."},{"issue":"7","key":"10.1016\/j.biopha.2019.109128_bib1090","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.progpolymsci.2011.01.001","article-title":"Polymer nanoparticles: preparation techniques and size-control parameters","volume":"36","author":"Rao","year":"2011","journal-title":"Prog. Polym. Sci."},{"issue":"6 Pt 3","key":"10.1016\/j.biopha.2019.109128_bib1095","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.biotechadv.2015.02.010","article-title":"Polymer-based nanoparticles for oral insulin delivery: revisited approaches","volume":"33","author":"Fonte","year":"2015","journal-title":"Biotechnol. Adv."},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib1100","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0031-6997(24)01494-7","article-title":"Long-circulating and target-specific nanoparticles: theory to practice","volume":"53","author":"Moghimi","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biopha.2019.109128_bib1105","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.biopha.2016.12.042","article-title":"Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: a synergistic combination nanotherapy for cervical cancer","volume":"86","author":"Li","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2019.109128_bib1110","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.biopha.2017.02.112","article-title":"Co-delivery of vincristine and quercetin by nanocarriers for lymphoma combination chemotherapy","volume":"91","author":"Zhu","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.biopha.2019.109128_bib1115","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/10611860802374303","article-title":"Novel polymeric nanoparticles containing tanshinone IIA for the treatment of hepatoma","volume":"16","author":"Li","year":"2008","journal-title":"J. Drug Target."},{"issue":"11","key":"10.1016\/j.biopha.2019.109128_bib1120","doi-asserted-by":"crossref","first-page":"181457","DOI":"10.1098\/rsos.181457","article-title":"Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy","volume":"5","author":"Wan","year":"2018","journal-title":"R. Soc. Open Sci."},{"issue":"9","key":"10.1016\/j.biopha.2019.109128_bib1125","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1080\/10717544.2016.1176087","article-title":"Quercetin-loaded poly (lactic-co-glycolic acid)-d-alpha-tocopheryl polyethylene glycol 1000 succinate nanoparticles for the targeted treatment of liver cancer","volume":"23","author":"Guan","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2019.109128_bib1130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-3155-5-3","article-title":"Polymeric nanoparticle-encapsulated curcumin (\"nanocurcumin\"): a novel strategy for human cancer therapy","volume":"5","author":"Bisht","year":"2007","journal-title":"J. Nanobiotechnology"},{"issue":"5","key":"10.1016\/j.biopha.2019.109128_bib1135","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1007\/s11095-012-0964-5","article-title":"Engineered andrographolide nanoparticles mitigate paracetamol hepatotoxicity in mice","volume":"30","author":"Roy","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2019.109128_bib1140","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2147\/IJN.S157391","article-title":"Poly(lactic-co-glycolic acid)-loaded nanoparticles of betulinic acid for improved treatment of hepatic cancer: characterization, in vitro and in vivo evaluations","volume":"13","author":"Kumar","year":"2018","journal-title":"Int. J. Nanomedicine"},{"issue":"1-2","key":"10.1016\/j.biopha.2019.109128_bib1145","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijpharm.2017.05.005","article-title":"Microemulsion utility in pharmaceuticals: implications for multi-drug delivery","volume":"526","author":"Callender","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib1150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1208\/s12249-017-0811-4","article-title":"Design and development of repaglinide microemulsion gel for transdermal delivery","volume":"19","author":"Shinde","year":"2018","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib1155","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s13346-017-0453-9","article-title":"Augmented bioavailability of felodipine through an alpha-linolenic acid-based microemulsion","volume":"8","author":"Singh","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"issue":"7","key":"10.1016\/j.biopha.2019.109128_bib1160","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1089\/jmf.2013.0033","article-title":"Protective effect of clove oil and eugenol microemulsions on fatty liver and dyslipidemia as components of metabolic syndrome","volume":"17","author":"Al-Okbi","year":"2014","journal-title":"J. Med. Food"},{"key":"10.1016\/j.biopha.2019.109128_bib1165","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2147\/IJN.S125293","article-title":"Octanoyl galactose ester-modified microemulsion system self-assembled by coix seed components to enhance tumor targeting and hepatoma therapy","volume":"12","author":"Qu","year":"2017","journal-title":"Int. J. Nanomedicine"},{"issue":"15","key":"10.1016\/j.biopha.2019.109128_bib1170","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.3748\/wjg.v22.i15.3962","article-title":"Norcantharidin combined with ABT-737 for hepatocellular carcinoma: therapeutic effects and molecular mechanisms","volume":"22","author":"Ren","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.biopha.2019.109128_bib1175","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/10717544.2013.840692","article-title":"Primary in vitro and in vivo evaluation of norcantharidin-chitosan\/poly (vinyl alcohol) for cancer treatment","volume":"21","author":"Li","year":"2014","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib1180","first-page":"155","article-title":"Antimetastatic effects of norcantharidin on hepatocellular carcinoma cells by up-regulating FAM46C expression","volume":"9","author":"Wan","year":"2017","journal-title":"Am. J. Transl. Res."},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib1185","first-page":"85","article-title":"Cisplatin plus norcantharidin alter the expression of TGF-beta1\/Smads signaling pathway in hepatocellular carcinoma","volume":"118","author":"Li","year":"2017","journal-title":"Bratisl. Lek. Listy"},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib1190","first-page":"609","article-title":"Norcantharidin reverses cisplatin resistance and inhibits the epithelial mesenchymal transition of human nonsmall lung cancer cells by regulating the YAP pathway","volume":"40","author":"Jin","year":"2018","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2019.109128_bib1195","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/10717540500176829","article-title":"An investigation on liver-targeting microemulsions of norcantharidin","volume":"12","author":"Zhang","year":"2005","journal-title":"Drug Deliv."},{"issue":"6","key":"10.1016\/j.biopha.2019.109128_bib1200","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1021\/ja512012m","article-title":"Controlling lipid micelle stability using oligonucleotide headgroups","volume":"137","author":"Wilner","year":"2015","journal-title":"J. Am. Chem. Soc."},{"issue":"10","key":"10.1016\/j.biopha.2019.109128_bib1205","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1200\/JCO.2005.03.134","article-title":"The effect of low molecular weight heparin on survival in patients with advanced malignancy","volume":"23","author":"Klerk","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.biopha.2019.109128_bib1210","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1517\/13543784.17.7.1029","article-title":"Heparin as an anticancer therapeutic","volume":"17","author":"Zacharski","year":"2008","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"1-2","key":"10.1016\/j.biopha.2019.109128_bib1215","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijpharm.2017.02.051","article-title":"Gambogic acid grafted low molecular weight heparin micelles for targeted treatment in a hepatocellular carcinoma model with an enhanced anti-angiogenesis effect","volume":"522","author":"Yan","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib1220","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/s41467-019-09852-0","article-title":"Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases","volume":"10","author":"Guo","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib1225","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.micromeso.2011.06.001","article-title":"3D cubic mesoporous silica microsphere as a carrier for poorly soluble drug carvedilol","volume":"147","author":"Hu","year":"2012","journal-title":"Microporous Mesoporous Mater."},{"issue":"5","key":"10.1016\/j.biopha.2019.109128_bib1230","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1021\/cm9033484","article-title":"Advanced drug delivery vectors with tailored surface properties made of mesoporous binary oxides submicronic spheres","volume":"22","author":"Colilla","year":"2010","journal-title":"Chem. Mater."},{"issue":"16","key":"10.1016\/j.biopha.2019.109128_bib1235","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/smll.201000538","article-title":"Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for Cancer therapy in animals","volume":"6","author":"Lu","year":"2010","journal-title":"Small"},{"issue":"26","key":"10.1016\/j.biopha.2019.109128_bib1240","doi-asserted-by":"crossref","first-page":"10740","DOI":"10.1039\/c3cp44614j","article-title":"Poly(propylene imine) dendrimer caps on mesoporous silica nanoparticles for redox-responsive release: smaller is better","volume":"15","author":"Nadrah","year":"2013","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"1-2","key":"10.1016\/j.biopha.2019.109128_bib1245","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijpharm.2015.05.010","article-title":"Multifunctional mesoporous silica nanoparticles mediated co-delivery of paclitaxel and tetrandrine for overcoming multidrug resistance","volume":"489","author":"Jia","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2019.109128_bib1250","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1007\/s11095-013-1214-1","article-title":"Solidified self-nanoemulsifying formulation for oral delivery of combinatorial therapeutic regimen: part II in vivo pharmacokinetics, antitumor efficacy and hepatotoxicity","volume":"31","author":"Jain","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2019.109128_bib1255","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.actbio.2016.05.012","article-title":"PEGylated lipid bilayer-supported mesoporous silica nanoparticle composite for synergistic co-delivery of axitinib and celastrol in multi-targeted cancer therapy","volume":"39","author":"Choi","year":"2016","journal-title":"Acta Biomater."},{"issue":"30","key":"10.1016\/j.biopha.2019.109128_bib1260","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1016\/j.biomaterials.2010.07.008","article-title":"An anti-ROS\/hepatic fibrosis drug delivery system based on salvianolic acid B loaded mesoporous silica nanoparticles","volume":"31","author":"He","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2019.109128_bib1265","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.colsurfb.2018.02.011","article-title":"Solid lipid nanoparticles as an efficient drug delivery system of olmesartan medoxomil for the treatment of hypertension","volume":"165","author":"Pandya","year":"2018","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biopha.2019.109128_bib1270","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.2147\/IJN.S51262","article-title":"Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles","volume":"8","author":"Xue","year":"2013","journal-title":"Int. J. Nanomedicine"},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib1275","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3390\/molecules22020277","article-title":"Resveratrol and grape extract-loaded solid lipid nanoparticles for the treatment of Alzheimer\u2019s disease","volume":"22","author":"Loureiro","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2019.109128_bib1280","first-page":"335","article-title":"Study on Targeting and in vitro Anti-oxidation of Baicalin Solid Lipid Nanoparticles","volume":"4","author":"Ping","year":"2012","journal-title":"Chinese Herb. Med."},{"issue":"2-3","key":"10.1016\/j.biopha.2019.109128_bib1285","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"47","author":"Mehnert","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2019.109128_bib1290","doi-asserted-by":"crossref","first-page":"305","DOI":"10.15171\/apb.2015.043","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: structure, preparation and application","volume":"5","author":"Naseri","year":"2015","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.biopha.2019.109128_bib1295","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.2147\/IJN.S84565","article-title":"Berberine-loaded solid lipid nanoparticles are concentrated in the liver and ameliorate hepatosteatosis in db\/db mice","volume":"10","author":"Xue","year":"2015","journal-title":"Int. J. Nanomedicine"},{"issue":"3","key":"10.1016\/j.biopha.2019.109128_bib1300","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/08982104.2013.868476","article-title":"Comparing different sterol containing solid lipid nanoparticles for targeted delivery of quercetin in hepatocellular carcinoma","volume":"24","author":"Varshosaz","year":"2014","journal-title":"J. Liposome Res."},{"issue":"3","key":"10.1016\/j.biopha.2019.109128_bib1305","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s40259-014-0086-1","article-title":"Attenuation of carbon tetrachloride-induced hepatic injury with curcumin-loaded solid lipid nanoparticles","volume":"28","author":"Singh","year":"2014","journal-title":"Biodrugs"},{"issue":"1\u20132","key":"10.1016\/j.biopha.2019.109128_bib1310","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijpharm.2015.02.070","article-title":"Development, optimization and evaluation of long chain nanolipid carrier for hepatic delivery of silymarin through lymphatic transport pathway","volume":"485","author":"Chaudhary","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2019.109128_bib1315","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/sj.mt.6300168","article-title":"Systemic and specific delivery of small interfering RNAs to the liver mediated by apolipoprotein A-I","volume":"15","author":"Kim","year":"2007","journal-title":"Mol. Ther."},{"issue":"41","key":"10.1016\/j.biopha.2019.109128_bib1320","doi-asserted-by":"crossref","first-page":"13282","DOI":"10.1021\/ja046735b","article-title":"Engineered protein cages for nanomaterial synthesis","volume":"126","author":"Kramer","year":"2004","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.biopha.2019.109128_bib1325","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jconrel.2008.05.010","article-title":"Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles","volume":"132","author":"Kratz","year":"2008","journal-title":"J. Control. Release"},{"issue":"15","key":"10.1016\/j.biopha.2019.109128_bib1330","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/smll.200801602","article-title":"Protein-based nanomedicine platforms for drug delivery","volume":"5","author":"Maham","year":"2009","journal-title":"Small"},{"key":"10.1016\/j.biopha.2019.109128_bib1335","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejps.2015.03.002","article-title":"Enhanced hepatic targeting, biodistribution and antifibrotic efficacy of tanshinone IIA loaded globin nanoparticles","volume":"73","author":"Meng","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"issue":"18","key":"10.1016\/j.biopha.2019.109128_bib1340","doi-asserted-by":"crossref","first-page":"8997","DOI":"10.1021\/acs.analchem.6b01443","article-title":"Construction of epidermal growth factor receptor peptide magnetic nanovesicles with lipid bilayers for enhanced capture of liver cancer circulating tumor cells","volume":"88","author":"Ding","year":"2016","journal-title":"Anal. Chem."},{"issue":"98","key":"10.1016\/j.biopha.2019.109128_bib1345","doi-asserted-by":"crossref","first-page":"14113","DOI":"10.1039\/C6CC07321B","article-title":"A drug-loaded nanoscale metal-organic framework with a tumor targeting agent for highly effective hepatoma therapy","volume":"52","author":"Li","year":"2016","journal-title":"Chem. Commun. (Camb.)"},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib1350","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1166\/jbn.2019.2682","article-title":"Nano-gold loaded with resveratrol enhance the anti-hepatoma effect of resveratrol in vitro and in vivo","volume":"15","author":"Zhang","year":"2019","journal-title":"J. Biomed. Nanotechnol."},{"issue":"6","key":"10.1016\/j.biopha.2019.109128_bib1355","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3109\/10717544.2014.898715","article-title":"Formulation and characterization of albumin microspheres containing norcantharidate for liver tumor targeting","volume":"22","author":"Yan","year":"2015","journal-title":"Drug Deliv."},{"issue":"5","key":"10.1016\/j.biopha.2019.109128_bib1360","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1021\/bc0501146","article-title":"A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 2. In vitro and in vivo uptake results","volume":"16","author":"Popielarski","year":"2005","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.biopha.2019.109128_bib1365","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jconrel.2015.02.022","article-title":"Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications","volume":"203","author":"D\u2019Souza","year":"2015","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.biopha.2019.109128_bib1370","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1016\/S0021-9258(18)32543-2","article-title":"The large intracellular pool of asialoglycoprotein receptors functions during the endocytosis of asialoglycoproteins by isolated rat hepatocytes","volume":"258","author":"Weigel","year":"1983","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib1375","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1083\/jcb.83.1.65","article-title":"An electron microscope autoradiographic study of the carbohydrate recognition systems in rat liver. II. Intracellular fates of the 125I-ligands","volume":"83","author":"Hubbard","year":"1979","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.biopha.2019.109128_bib1380","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.phrs.2011.06.015","article-title":"A galactosamine-mediated drug delivery carrier for targeted liver cancer therapy","volume":"64","author":"Shen","year":"2011","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.biopha.2019.109128_bib1385","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1055\/s-2006-957894","article-title":"Anti-inflammatory and anti-nociceptive activity of disodium glycyrrhetinic acid hemiphthalate","volume":"62","author":"Khaksa","year":"1996","journal-title":"Planta Med."},{"issue":"13\u201314","key":"10.1016\/j.biopha.2019.109128_bib1390","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.lfs.2008.07.014","article-title":"18beta-Glycyrrhetinic acid induces apoptotic cell death in SiHa cells and exhibits a synergistic effect against antibiotic anti-cancer drug toxicity","volume":"83","author":"Lee","year":"2008","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.biopha.2019.109128_bib1395","doi-asserted-by":"crossref","DOI":"10.1016\/0031-9422(92)83257-Y","article-title":"Triterpenoids","volume":"31","author":"Mahato","year":"1992","journal-title":"Phytochemistry"},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib1400","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1055\/s-2006-959435","article-title":"A comparison of the antihepatotoxic activity between glycyrrhizin and glycyrrhetinic acid","volume":"60","author":"Nose","year":"1994","journal-title":"Planta Med."},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib1405","first-page":"128","article-title":"Protective effect of glycyrrhizin, glycyrrhetic acid and matrine on acute cholestasis induced by alpha-naphthyl isothiocyanate in rats","volume":"73","author":"Zhai","year":"2007","journal-title":"Planta Med."},{"issue":"4","key":"10.1016\/j.biopha.2019.109128_bib1410","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1248\/cpb.39.1004","article-title":"Targeting of liposomes surface-modified with glycyrrhizin to the liver. I. Preparation and biological disposition","volume":"39","author":"Tsuji","year":"1991","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"issue":"3","key":"10.1016\/j.biopha.2019.109128_bib1415","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1248\/bpb.16.293","article-title":"Uptake of glycyrrhizin by isolated rat hepatocytes","volume":"16","author":"Ishida","year":"1993","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib1420","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0005-2736(91)90253-5","article-title":"Specific binding of glycyrrhetinic acid to the rat liver membrane","volume":"1066","author":"Negishi","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib1425","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3109\/21691401.2014.962747","article-title":"Preparation and evaluation of liver-targeting micelles loaded with oxaliplatin","volume":"44","author":"Yan","year":"2016","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"11","key":"10.1016\/j.biopha.2019.109128_bib1430","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.3109\/03639040902939197","article-title":"Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting","volume":"35","author":"Lin","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.biopha.2019.109128_bib1435","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1289\/ehp.793379","article-title":"Properties and biological significance of the ileal bile salt transport system","volume":"33","author":"Lack","year":"1979","journal-title":"Environ. Health Perspect."},{"issue":"3","key":"10.1016\/j.biopha.2019.109128_bib1440","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000450983","article-title":"Bile acid uptake transporters as targets for therapy","volume":"35","author":"Slijepcevic","year":"2017","journal-title":"Dig. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib1445","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1172\/JCI108302","article-title":"Identification and characterization of a bile acid receptor in isolated liver surface membranes","volume":"57","author":"Accatino","year":"1976","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2019.109128_bib1450","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.2147\/IJN.S33139","article-title":"Recombinant high-density lipoprotein nanoparticles containing gadolinium-labeled cholesterol for morphologic and functional magnetic resonance imaging of the liver","volume":"7","author":"Rui","year":"2012","journal-title":"Int. J. Nanomedicine"},{"issue":"9","key":"10.1016\/j.biopha.2019.109128_bib1455","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3109\/03639045.2011.637052","article-title":"Preparation and evaluation of paclitaxel-loaded nanoparticle incorporated with galactose-carrying polymer for hepatocyte targeted delivery","volume":"38","author":"Wang","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1-2","key":"10.1016\/j.biopha.2019.109128_bib1460","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijpharm.2005.02.027","article-title":"Cellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly(gamma-benzyl L-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety","volume":"296","author":"Jeong","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"30","key":"10.1016\/j.biopha.2019.109128_bib1465","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1016\/j.biomaterials.2012.06.072","article-title":"Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma","volume":"33","author":"Shi","year":"2012","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib1470","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.nano.2017.10.007","article-title":"A self-assembly nanodrug delivery system based on amphiphilic low generations of PAMAM dendrimers-ursolic acid conjugate modified by lactobionic acid for HCC targeting therapy","volume":"14","author":"Shen","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2019.109128_bib1475","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.actbio.2018.01.028","article-title":"Carrier-free nanodrug by co-assembly of chemotherapeutic agent and photosensitizer for cancer imaging and chemo-photo combination therapy","volume":"70","author":"Zhao","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2019.109128_bib1480","first-page":"1207","article-title":"Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery","volume":"8","author":"Zu","year":"2013","journal-title":"Int. J. Nanomedicine"},{"issue":"10","key":"10.1016\/j.biopha.2019.109128_bib1485","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1007\/s11095-015-1714-2","article-title":"Glycyrrhetinic acid-mediated polymeric drug delivery targeting the acidic microenvironment of hepatocellular carcinoma","volume":"32","author":"Zhang","year":"2015","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib1490","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1166\/jbn.2018.2467","article-title":"Glycyrrhetinic acid-modified norcantharidin nanoparticles for active targeted therapy of hepatocellular carcinoma","volume":"14","author":"Zhang","year":"2018","journal-title":"J. Biomed. Nanotechnol."},{"issue":"5","key":"10.1016\/j.biopha.2019.109128_bib1495","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.3109\/10717544.2015.1108374","article-title":"Liver-targeting self-assembled hyaluronic acid-glycyrrhetinic acid micelles enhance hepato-protective effect of silybin after oral administration","volume":"23","author":"Han","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2019.109128_bib1500","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.molimm.2017.02.018","article-title":"The role of Kupffer cells in hepatic diseases","volume":"85","author":"Li","year":"2017","journal-title":"Mol. Immunol."},{"issue":"43","key":"10.1016\/j.biopha.2019.109128_bib1505","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.3748\/wjg.v23.i43.7666","article-title":"Pathological process of liver sinusoidal endothelial cells in liver diseases","volume":"23","author":"Ni","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib1510","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5582\/bst.2017.01007","article-title":"Key role of liver sinusoidal endothelial cells in liver fibrosis","volume":"11","author":"Xu","year":"2017","journal-title":"Biosci. Trends"},{"issue":"5","key":"10.1016\/j.biopha.2019.109128_bib1515","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1034\/j.1600-0676.2001.210504.x","article-title":"Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin (M6P28-HSA)","volume":"21","author":"Beljaars","year":"2001","journal-title":"Liver Int."},{"key":"10.1016\/j.biopha.2019.109128_bib1520","first-page":"221","volume":"137B","author":"Pontow","year":"1992","journal-title":"Mannose Receptor"},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib1525","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1128\/IAI.71.1.437-445.2003","article-title":"Normal host defense during systemic candidiasis in mannose receptor-deficient mice","volume":"71","author":"Lee","year":"2003","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib1530","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jconrel.2010.03.010","article-title":"Genetically engineered mannosylated-human serum albumin as a versatile carrier for liver-selective therapeutics","volume":"145","author":"Hirata","year":"2010","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib1535","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1432-1033.1996.00344.x","article-title":"Quantitative analysis of the targeting of mannose-terminal glucocerebrosidase. Predominant uptake by liver endothelial cells","volume":"237","author":"Bijsterbosch","year":"1996","journal-title":"Eur. J. Biochem."},{"issue":"10","key":"10.1016\/j.biopha.2019.109128_bib1540","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3390\/molecules22101598","article-title":"Glycyrrhetinic acid liposomes containing mannose-diester lauric diacid-cholesterol conjugate synthesized by lipase-catalytic acylation for liver-specific delivery","volume":"22","author":"Chen","year":"2017","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib1545","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1021\/bc800237t","article-title":"HPMA polymer-based site-specific delivery of oligonucleotides to hepatic stellate cells","volume":"20","author":"Yang","year":"2009","journal-title":"Bioconjug. Chem."},{"issue":"17","key":"10.1016\/j.biopha.2019.109128_bib1550","doi-asserted-by":"crossref","first-page":"12743","DOI":"10.1074\/jbc.275.17.12743","article-title":"Successful targeting to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor","volume":"275","author":"Beljaars","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"26","key":"10.1016\/j.biopha.2019.109128_bib1555","doi-asserted-by":"crossref","first-page":"265101","DOI":"10.1088\/0957-4484\/23\/26\/265101","article-title":"The improving effects on hepatic fibrosis of interferon-gamma liposomes targeted to hepatic stellate cells","volume":"23","author":"Li","year":"2012","journal-title":"Nanotechnology"},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib1560","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/ijerph14010011","article-title":"Ameliorative effect of curcumin-encapsulated hyaluronic Acid-PLA nanoparticles on thioacetamide-induced murine hepatic fibrosis","volume":"14","author":"Chen","year":"2016","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.biopha.2019.109128_bib1565","doi-asserted-by":"crossref","first-page":"33910","DOI":"10.1038\/srep33910","article-title":"Identifying anticancer peptides by using improved hybrid compositions","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2019.109128_bib1570","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/IJN.S27226","article-title":"Anti-tumor effects of brucine immuno-nanoparticles on hepatocellular carcinoma","volume":"7","author":"Qin","year":"2012","journal-title":"Int. J. Nanomedicine"},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib1575","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.clim.2006.06.010","article-title":"The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer","volume":"121","author":"Daniels","year":"2006","journal-title":"Clin. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2019.109128_bib1580","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3109\/03639045.2016.1160103","article-title":"Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin","volume":"42","author":"Zhang","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"7463","key":"10.1016\/j.biopha.2019.109128_bib1585","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature12327","article-title":"Structural basis for molecular recognition of folic acid by folate receptors","volume":"500","author":"Chen","year":"2013","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.biopha.2019.109128_bib1590","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.addr.2004.02.003","article-title":"Folate receptor-targeted drugs for cancer and inflammatory diseases","volume":"56","author":"Low","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2019.109128_bib1595","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s10544-008-9180-9","article-title":"Folate-functionalized polymeric micelle as hepatic carcinoma-targeted, MRI-ultrasensitive delivery system of antitumor drugs","volume":"10","author":"Hong","year":"2008","journal-title":"Biomed. Microdevices"},{"key":"10.1016\/j.biopha.2019.109128_bib1600","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2147\/IJN.S96862","article-title":"Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo","volume":"11","author":"Liu","year":"2016","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.biopha.2019.109128_bib1605","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.colsurfb.2014.05.005","article-title":"Development of a folate-modified curcumin loaded micelle delivery system for cancer targeting","volume":"121","author":"Yang","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib1610","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/21691401.2018.1548468","article-title":"Folate-conjugated human serum albumin-encapsulated resveratrol nanoparticles: preparation, characterization, bioavailability and targeting of liver tumors","volume":"47","author":"Lian","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.biopha.2019.109128_bib1615","doi-asserted-by":"crossref","first-page":"17489","DOI":"10.1016\/S0021-9258(19)85360-7","article-title":"Cytokine regulation of low density lipoprotein receptor gene transcription in HepG2 cells","volume":"268","author":"Stopeck","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2019.109128_bib1620","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1021\/bc00026a002","article-title":"Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells","volume":"5","author":"Firestone","year":"2002","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.biopha.2019.109128_bib1625","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.2147\/IJN.S59799","article-title":"N-Succinyl-chitosan nanoparticles coupled with low-density lipoprotein for targeted osthole-loaded delivery to low-density lipoprotein receptor-rich tumors","volume":"9","author":"Zhang","year":"2014","journal-title":"Int. J. Nanomedicine"},{"issue":"3","key":"10.1016\/j.biopha.2019.109128_bib1630","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/1414-431x20176650","article-title":"Low density lipoprotein modified silica nanoparticles loaded with docetaxel and thalidomide for effective chemotherapy of liver cancer","volume":"51","author":"Ao","year":"2018","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.biopha.2019.109128_bib1635","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.2147\/IJN.S156616","article-title":"Tumor-targeting delivery of herb-based drugs with cell-penetrating\/tumor-targeting peptide-modified nanocarriers","volume":"13","author":"Kebebe","year":"2018","journal-title":"Int. J. Nanomedicine"},{"issue":"11","key":"10.1016\/j.biopha.2019.109128_bib1640","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1166\/jbn.2014.1982","article-title":"Targeted delivery of tanshinone IIA-conjugated mPEG-PLGA-PLL-cRGD nanoparticles to hepatocellular carcinoma","volume":"10","author":"Wang","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"issue":"1-2","key":"10.1016\/j.biopha.2019.109128_bib1645","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ijpharm.2012.10.030","article-title":"Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs","volume":"441","author":"Zhang","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2019.109128_bib1650","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1080\/10717544.2018.1461957","article-title":"Preparation of poly-l-lysine-based nanoparticles with pH-sensitive release of curcumin for targeted imaging and therapy of liver cancer in vitro and in vivo","volume":"25","author":"Yang","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2019.109128_bib1655","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ejps.2016.10.019","article-title":"pH-Sensitive mesoporous silica nanoparticles anticancer prodrugs for sustained release of ursolic acid and the enhanced anti-cancer efficacy for hepatocellular carcinoma cancer","volume":"96","author":"Li","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2019.109128_bib1660","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1021\/acs.molpharmaceut.8b00564","article-title":"Co-delivery of doxorubicin and interferon-gamma by thermosensitive nanoparticles for cancer immunochemotherapy","volume":"15","author":"Yin","year":"2018","journal-title":"Mol. Pharm."},{"issue":"13","key":"10.1016\/j.biopha.2019.109128_bib1665","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1039\/C8NR90055H","article-title":"Correction: a smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53\/MMP-9\/PTEN\/CD44 mediated multiple signaling pathways","volume":"10","author":"Jiang","year":"2018","journal-title":"Nanoscale"},{"issue":"50","key":"10.1016\/j.biopha.2019.109128_bib1670","doi-asserted-by":"crossref","first-page":"43508","DOI":"10.1021\/acsami.7b14755","article-title":"A small molecule nanodrug by self-assembly of dual anticancer drugs and photosensitizer for synergistic near-infrared cancer theranostics","volume":"9","author":"Guo","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"7","key":"10.1016\/j.biopha.2019.109128_bib1675","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1021\/nn301714n","article-title":"Cytotoxic effects of gold nanoparticles: a multiparametric study","volume":"6","author":"Soenen","year":"2012","journal-title":"ACS Nano"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219314179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219314179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T09:16:45Z","timestamp":1773911805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332219314179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":335,"alternative-id":["S0753332219314179"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109128","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traditional Chinese medicine combined with hepatic targeted drug delivery systems: A new strategy for the treatment of liver diseases","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109128","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"109128"}}